MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions
MoonLake To Tap Into Komodo’s Technology and Real-World Data To Unlockthe Full Potential of Its Next-Gen Nanobody® Therapy SAN FRANCISCO/ZUG, SWITZERLAND, April 10, 2024 — MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX), a clinical-stage...